These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 23169332)

  • 21. Changing patterns in HIV/AIDS stigma and uptake of voluntary counselling and testing services: the results of two consecutive community surveys conducted in the Western Cape, South Africa.
    Mall S; Middelkoop K; Mark D; Wood R; Bekker LG
    AIDS Care; 2013; 25(2):194-201. PubMed ID: 22694602
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Non-enrollment for free community HIV care: findings from a population-based study in Rakai, Uganda.
    Nakigozi G; Makumbi F; Reynolds S; Galiwango R; Kagaayi J; Nalugoda F; Ssettuba A; Sekasanvu J; Musuuza J; Serwada D; Gray R; Wawer M
    AIDS Care; 2011 Jun; 23(6):764-70. PubMed ID: 21293989
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Neurocognitive and motor deficits in HIV-infected Ugandan children with high CD4 cell counts.
    Ruel TD; Boivin MJ; Boal HE; Bangirana P; Charlebois E; Havlir DV; Rosenthal PJ; Dorsey G; Achan J; Akello C; Kamya MR; Wong JK
    Clin Infect Dis; 2012 Apr; 54(7):1001-9. PubMed ID: 22308272
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Clinical and behavioral characteristics of adults receiving medical care for HIV infection --- Medical Monitoring Project, United States, 2007.
    Blair JM; McNaghten AD; Frazier EL; Skarbinski J; Huang P; Heffelfinger JD
    MMWR Surveill Summ; 2011 Sep; 60(11):1-20. PubMed ID: 21881551
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Failure to initiate antiretroviral therapy, loss to follow-up and mortality among HIV-infected patients during the pre-ART period in Uganda.
    Geng EH; Bwana MB; Muyindike W; Glidden DV; Bangsberg DR; Neilands TB; Bernheimer I; Musinguzi N; Yiannoutsos CT; Martin JN
    J Acquir Immune Defic Syndr; 2013 Jun; 63(2):e64-71. PubMed ID: 23429504
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Utility of routine viral load, CD4 cell count, and clinical monitoring among adults with HIV receiving antiretroviral therapy in Uganda: randomised trial.
    Mermin J; Ekwaru JP; Were W; Degerman R; Bunnell R; Kaharuza F; Downing R; Coutinho A; Solberg P; Alexander LN; Tappero J; Campbell J; Moore DM
    BMJ; 2011 Nov; 343():d6792. PubMed ID: 22074711
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Optimal time for initiation of antiretroviral therapy in asymptomatic, HIV-infected, treatment-naive adults.
    Siegfried N; Uthman OA; Rutherford GW
    Cochrane Database Syst Rev; 2010 Mar; 2010(3):CD008272. PubMed ID: 20238364
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pulmonary effects of immediate versus deferred antiretroviral therapy in HIV-positive individuals: a nested substudy within the multicentre, international, randomised, controlled Strategic Timing of Antiretroviral Treatment (START) trial.
    Kunisaki KM; Niewoehner DE; Collins G; Aagaard B; Atako NB; Bakowska E; Clarke A; Corbelli GM; Ekong E; Emery S; Finley EB; Florence E; Infante RM; Kityo CM; Madero JS; Nixon DE; Tedaldi E; Vestbo J; Wood R; Connett JE;
    Lancet Respir Med; 2016 Dec; 4(12):980-989. PubMed ID: 27773665
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Education attainment as a predictor of HIV risk in rural Uganda: results from a population-based study.
    Smith J; Nalagoda F; Wawer MJ; Serwadda D; Sewankambo N; Konde-Lule J; Lutalo T; Li C; Gray RH
    Int J STD AIDS; 1999 Jul; 10(7):452-9. PubMed ID: 10454180
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Successful antiretroviral therapy delivery and retention in care among asymptomatic individuals with high CD4+ T-cell counts above 350 cells/μl in rural Uganda.
    Jain V; Byonanebye DM; Amanyire G; Kwarisiima D; Black D; Kabami J; Chamie G; Clark TD; Rooney JF; Charlebois ED; Kamya MR; Havlir DV;
    AIDS; 2014 Sep; 28(15):2241-9. PubMed ID: 25022596
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Mortality in the year following antiretroviral therapy initiation in HIV-infected adults and children in Uganda and Zimbabwe.
    Walker AS; Prendergast AJ; Mugyenyi P; Munderi P; Hakim J; Kekitiinwa A; Katabira E; Gilks CF; Kityo C; Nahirya-Ntege P; Nathoo K; Gibb DM;
    Clin Infect Dis; 2012 Dec; 55(12):1707-18. PubMed ID: 22972859
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Optimal time for initiating antiretroviral therapy (ART) in HIV-infected, treatment-naive children aged 2 to 5 years old.
    Siegfried N; Davies MA; Penazzato M; Muhe LM; Egger M
    Cochrane Database Syst Rev; 2013 Oct; 10(10):CD010309. PubMed ID: 24114324
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Within and between race differences in lymphocyte, CD4+, CD8+ and neutrophil levels in HIV-uninfected children with or without HIV exposure in Europe and Uganda.
    Bunders M; Lugada E; Mermin J; Downing R; Were W; Thorne C; Newell ML;
    Ann Trop Paediatr; 2006 Sep; 26(3):169-79. PubMed ID: 16925953
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Estimated Costs for Delivery of HIV Antiretroviral Therapy to Individuals with CD4+ T-Cell Counts >350 cells/uL in Rural Uganda.
    Jain V; Chang W; Byonanebye DM; Owaraganise A; Twinomuhwezi E; Amanyire G; Black D; Marseille E; Kamya MR; Havlir DV; Kahn JG
    PLoS One; 2015; 10(12):e0143433. PubMed ID: 26632823
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Unconditional cash transfers for clinical and economic outcomes among HIV-affected Ugandan households.
    Mills EJ; Adhvaryu A; Jakiela P; Birungi J; Okoboi S; Chimulwa TNW; Wanganisi J; Achilla T; Popoff E; Golchi S; Karlan D
    AIDS; 2018 Sep; 32(14):2023-2031. PubMed ID: 29847330
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Risk factors for delayed initiation of combination antiretroviral therapy in rural north central Nigeria.
    Aliyu MH; Blevins M; Parrish DD; Megazzini KM; Gebi UI; Muhammad MY; Ahmed ML; Hassan A; Shepherd BE; Vermund SH; Wester CW
    J Acquir Immune Defic Syndr; 2014 Feb; 65(2):e41-9. PubMed ID: 23727981
    [TBL] [Abstract][Full Text] [Related]  

  • 37. CD4+ cell count at antiretroviral therapy initiation and economic restoration in rural Uganda.
    Venkataramani AS; Thirumurthy H; Haberer JE; Ii YB; Siedner MJ; Kembabazi A; Hunt PW; Martin JN; Bangsberg DR; Tsai AC
    AIDS; 2014 May; 28(8):1221-6. PubMed ID: 24406678
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Alcohol use and immune reconstitution among HIV-infected patients on antiretroviral therapy in Nairobi, Kenya.
    Cagle A; McGrath C; Richardson BA; Donovan D; Sakr S; Yatich N; Ngomoa R; Chepngeno Langat A; John-Stewart G; Chung MH
    AIDS Care; 2017 Sep; 29(9):1192-1197. PubMed ID: 28132519
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Gender differences in antiretroviral treatment outcomes of HIV patients in rural Uganda.
    Kipp W; Alibhai A; Saunders LD; Senthilselvan A; Kaler A; Konde-Lule J; Okech-Ojony J; Rubaale T
    AIDS Care; 2010 Mar; 22(3):271-8. PubMed ID: 20390506
    [TBL] [Abstract][Full Text] [Related]  

  • 40. HIV-infected ugandan adults taking antiretroviral therapy with CD4 counts >200 cells/μL who discontinue cotrimoxazole prophylaxis have increased risk of malaria and diarrhea.
    Campbell JD; Moore D; Degerman R; Kaharuza F; Were W; Muramuzi E; Odongo G; Wetaka M; Mermin J; Tappero JW
    Clin Infect Dis; 2012 Apr; 54(8):1204-11. PubMed ID: 22423133
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.